Ha, Yeonjung
Mohamed Ali, Mohamed A.
Petersen, Molly M.
Harmsen, William S.
Therneau, Terry M.
Lee, Han Chu
Ryoo, Baek-Yeol
Bampoh, Sally
Valles, Kenneth A.
Mady, Mohamad
Missula, Venkata R.
Prasai, Kritika
Roberts, Lewis R.
Kim, Kang Mo http://orcid.org/0000-0002-3180-3178
Funding for this research was provided by:
National Institutes of Health (R01 CA 186566)
Mayo Clinic (P50 CA 210964)
Center for Clinical and Translational Science, Mayo Clinic (UL1 TR 002377)
Article History
Received: 21 April 2020
Accepted: 15 July 2020
First Online: 1 August 2020
Compliance with ethical standards
:
: Dr. Lewis Roberts has received grant support from ARIAD Pharmaceuticals, Bayer, BTG International, Exact Sciences, Gilead Sciences, Glycotest Inc., RedHill Inc., Target PharmaSolutions, and Wako Diagnostics; he has provided advisory services to Bayer, Exact Sciences, Gilead Sciences, GRAIL Inc., QED Therapeutics and TAVEC. The other authors have no conflicts of interests to declare.
: The institutional review board of the Asan Medical Center (approval number: 2019-0685) and the Mayo Clinic (approval number: 15-006298) granted a waiver of informed consent and approval of this observational study with deidentified data.